Form 8-K - Current report:
SEC Accession No. 0000950103-23-016461
Filing Date
2023-11-20
Accepted
2023-11-20 06:11:05
Documents
12
Period of Report
2023-11-19
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp202963_8k.htm   iXBRL 8-K 30905
  Complete submission text file 0000950103-23-016461.txt   207490

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE prok-20231119.xsd EX-101.SCH 3018
3 XBRL LABEL FILE prok-20231119_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE prok-20231119_pre.xml EX-101.PRE 22361
6 EXTRACTED XBRL INSTANCE DOCUMENT dp202963_8k_htm.xml XML 3428
Mailing Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103
Business Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103 336-999-7028
PROKIDNEY CORP. (Filer) CIK: 0001850270 (see all company filings)

EIN.: 981586514 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40560 | Film No.: 231420659
SIC: 2836 Biological Products, (No Diagnostic Substances)